Oct

20

Other Issuances: OIG audits Epogen, oxaliplatin, Region B RAC updates issues, and more

By Medicare Weekly Update

CGI updates approved audit issues

CGI Federal, the RAC for Region B, has posted an updated list of approved audit issues.

View the updated list.

OIG audits Epogen payments

On October 8, the OIG issued two audit reports on payments for Epogen administration at University of Virginia Medical Center–Lynchburg Dialysis and Bon Secours Baltimore Hospital Renal Dialysis Center. The OIG found that the facilities did not meet Medicare payment requirements for some dates of service and that policies and procedures were not always followed.

View the OIG report on Epogen reimbursement to the University of Virginia Medical Center–Lynchburg Dialysis.

View the OIG report on Epogen reimbursement to the University of Bon Secours Baltimore Hospital Renal Dialysis Center.

OIG audits oxaliplatin payments

On October 7, the OIG issued an audit report of payments for oxaliplatin administration made during 2005 by National Government Services (NGS), a Medicare fiscal intermediary for West Virginia. The OIG determined that NGS made overpayments totaling $433,000 for oxaliplatin drug services.

View the OIG report.

CMS posts new RAC FAQ

Will Code N432 appear on the remittance advice for Recovery Audit Contractor (RAC) adjusted claims?

Read the answer.